about
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence.Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cellsConcurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAFCell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigensSerological survey of normal humans for natural antibody to cell surface antigens of melanomaGenetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.AU cell-surface antigen of human malignant melanoma: solubilization and partial characterizationLoss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity.Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.Aberrant elevation of tyrosine-specific phosphorylation in human gastric cancer cells.Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.A molecular mechanism of complement resistance of human melanoma cells.Human tumor lines for cancer research.A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.
P4510
Q27852894-14AA8751-3A3A-4D3D-BDDC-FE88753496ECQ33850807-85A46DA1-ED09-470F-9BBC-4A55AFC57797Q35025264-0BF6CF78-5FE6-4ABC-838A-03FBC76BACFDQ35700459-F20320F7-C535-4CBE-A903-02265BABE7C7Q36247943-681544D5-916B-40C6-9D3A-647973926532Q36347214-E1328278-C849-45EF-AED2-6B11D1407450Q36359942-1BB9037B-5754-4304-B374-7A3A472723FCQ36399013-6F8E9E2F-3C21-492C-A2F4-DB8E67F5655BQ36982042-86B4EBE0-9332-42CA-AC64-2D66DC75A0DBQ37333876-B5708C68-D2D8-4965-9C59-560E63BEBA68Q37679541-7B874B2E-5097-4ADC-A141-D7FEA2C0A05BQ40887108-F6FF2B64-35C3-45AD-A4BC-DB1C51D84922Q42799579-341CFBE8-29E1-42E9-A093-88E9255065D1Q42808318-F397F1DD-2182-4DE7-BF51-D673F02BF0EDQ42818580-FEC1DA4E-E82E-4CF3-96DD-0C2157FDA6C5Q42820381-09FA71C3-331E-4503-8957-77C88767B9F5Q52826141-F31FCCA1-9F37-4061-9DD4-17B9C318654DQ52834172-58D5C299-9DCB-4D73-8D6C-B50A3AE102FB
P4510
description
Zelllinie
@de
ceall-líne
@ga
cell line
@en
cellijn van een Homo sapiens
@nl
lignée cellulaire
@fr
name
SK-MEL-37
@de
SK-MEL-37
@en
SK-MEL-37
@fr
SK-MEL-37
@ga
SK-MEL-37
@nl
type
label
SK-MEL-37
@de
SK-MEL-37
@en
SK-MEL-37
@fr
SK-MEL-37
@ga
SK-MEL-37
@nl
altLabel
BD-Mel
@en
SK MEL 37
@en
SK-37
@en
SK-MEL37
@en
SK-Mel 37
@en
SK-Mel-37
@en
SK37-MEL
@en
SKMEL-37
@en
Sk Mel37
@en
prefLabel
SK-MEL-37
@de
SK-MEL-37
@en
SK-MEL-37
@fr
SK-MEL-37
@ga
SK-MEL-37
@nl